Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Synuclein Proteins in Cancer Development and Progression

Version 1 : Received: 5 May 2023 / Approved: 10 May 2023 / Online: 10 May 2023 (13:58:12 CEST)

A peer-reviewed article of this Preprint also exists.

Zanotti, L.C.; Malizia, F.; Cesatti Laluce, N.; Avila, A.; Mamberto, M.; Anselmino, L.E.; Menacho-Márquez, M. Synuclein Proteins in Cancer Development and Progression. Biomolecules 2023, 13, 980. Zanotti, L.C.; Malizia, F.; Cesatti Laluce, N.; Avila, A.; Mamberto, M.; Anselmino, L.E.; Menacho-Márquez, M. Synuclein Proteins in Cancer Development and Progression. Biomolecules 2023, 13, 980.

Abstract

Synucleins are a family of small, soluble proteins mainly expressed in neural tissue and in certain tumors. Since their discovery, tens of thousands of scientific reports have been published about this family of proteins as they are associated to severe human diseases. Although the physiological function of these proteins still elusive, their relation with neurodegeneration and cancer was clearly described over the years. In this review, we summarize data connecting synucleins and cancer, going from the structural description of these molecules, to their involvement in tumor-related processes, and discuss the putative use of this proteins as cancer molecular biomarkers.

Keywords

synucleins; cancer; aggregation; pathways; biomarkers

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.